Unveiling the AI Dominance in Biopharma: STAT Post JPM Conference Insights

At health care’s biggest investor conference, AI’s high hopes collided with skepticism - STAT article

JPM conference has echoed discussions about AI across the biopharmaceutical landscape. Catch up on key insights shared in the latest STAT article titled: “At Health Care’s Biggest Investor Conference, AI’s High Hopes Collided with Skepticism.” Sanofi’s chief executive, Paul Hudson, revealed the widespread integration of AI within the company: “More than 11,000 people across the […]

Servier Will Apply Aitia’s Gemini Digital Twins to Parkinson’s Drug

Servier Will Apply Aitia's Digital Twins to Parkinson’s Drug

Spotlight on our joint effort with Servier, strengthening our partnership by entering a new collaboration focused on neuroscience. The aim of this cooperation is to leverage Aitia’s Gemini Digital Twins to identify patients most likely to respond positively to Servier’s Leucine-Rich-Repeat-Kinase 2 inhibitor (LRRK2i) in development treatment for Parkinson’s disease. Read the full article on […]